Brief: Lansen pharmaceutical issues profit warning
07/03/2016 10:12
March 7 (Reuters) - Lansen Pharmaceutical Holdings Ltd 0503.HK : * Pharma-profit warning 0503.HK * Expected to record decrease in profit from operations for 2015 * Expected reason due to a decrease in sales of leflunomide tablets in its specialty drugs portfolio * Source text (http://bit.ly/1L9Yl62) ((For more news, please click here 0503.HK )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year